Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04414982 · ClinicalTrials.gov registry record · NA

An Intervention to Increase Engagement With Hypertension Care for American Indian Patients

A NA study, sponsored by University of Colorado, Denver.

Completed
Registry status
NA
Development phase
339
Enrollment target

NCT04414982: Completed NA study, sponsored by University of Colorado, Denver.

NCT04414982 is a NA study that has completed, run by University of Colorado, Denver. The registered enrollment target is 339 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (76% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04414982, a NA study, has completed, sponsored by University of Colorado, Denver.

COMPLETED
Registry status
NA
Development phase
339 participants
Enrollment target

Study Summary

The objective of this study is to reduce the effects of stereotype threat on the adherence of American Indian/Alaska Native patients with hypertension. The specific aims of this study, which employs a values affirmation intervention, are to: 1. Compare the effects of the values-affirmation exercise with a control exercise in AI/AN patients with hypertension. 2. Compare the effects of the values-affirmation exercise in AI/AN patients with its effects in white patients.

Primary Outcome

This antihypertensive medication adherence outcome will be a summary measure of adherence which assesses the proportion of days covered (PDC) over the period of observation for which a patient obtains antihypertensive medications. Adherence will be calculated for each antihypertensive drug in the regimen and combined across drugs into a summary measure of adherence for the entire drug regimen.

Interventions

  • BEHAVIORAL Intervention Values Affirmation
  • BEHAVIORAL Control Values Affirmation

Trial Details

FieldValue
Enrollment Target 339 participants
Start Date 2015-09-01
Est. Completion 2020-06-30
Phase NA
University of Colorado, Denver

1,283 total trials

What the finished NCT04414982 record still lists

NCT04414982 is an interventional study that assigns participants to a tested intervention. The registered 339 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (76% lower).

The record links to 0 conditions, and to 2 interventions - of which Intervention Values Affirmation is the first listed.

NCT04414982 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04414982 about?

NCT04414982 is a clinical study titled "An Intervention to Increase Engagement With Hypertension Care for American Indian Patients". The objective of this study is to reduce the effects of stereotype threat on the adherence of American Indian/Alaska Native patients with hypertension. The specific aims of this study, which employs a values affirmation intervention, are to: 1. Compare the effects of the values-affirmation exercis...

What is the current status of trial NCT04414982?

This trial is currently completed. It is a NA study. The enrollment target is 339 participants. The study started on 2015-09-01. Estimated completion is 2020-06-30.

What interventions are being tested in trial NCT04414982?

The interventions under investigation include: Intervention Values Affirmation (BEHAVIORAL), Control Values Affirmation (BEHAVIORAL).

Who is sponsoring clinical trial NCT04414982?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04414982's enrollment target sits among peer trials

339 305th of 2000 higher than 1,696 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04176172 · 340 participants · Phase 3

    Optimizing Tobacco Use Treatment for PLWHA

  • NCT04545424 · 340 participants · Phase 2

    Trial of Therapeutic Hypothermia in Patients With ARDS

  • NCT04806958 · 340 participants · NA

    The PulsePoint Study

  • NCT05323409 · 340 participants · NA

    Improving Comprehensive Care of Cancer Patients

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04414982, the US trial registry maintained by the National Library of Medicine. NCT04414982 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.